FDA gives nod to Moderna vaccine for Covid-19
The company's vaccine is the second approved for emergency use by the FDA. It is expected to pose fewer logistical challenges than the first, which was developed by Pfizer and BioNTech.
AstraZeneca, Oxford are latest to unveil Covid-19 vaccine results
The partners pooled results from two trials and two different dosing regimens, one appearing to be more effective than the other. They hope to produce 3 billion doses in 2021 with an emphasis on serving poorer countries.
presented by
Transforming Patient Care: The Role of AI-Powered Assistants
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
With 90% efficacy against Covid-19, Pfizer/BioNTech’s vaccine jumps ahead in global race
The news sent the stock market soaring as it represents a key milestone in developing and distributing a vaccine for the virus. Still public confidence in vaccines need to be boosted, an expert noted.
Report: Trump sets sights on another unproven Covid-19 drug, this time from Fujifilm
Politico reported Tuesday that the Trump administration is trying to secure an emergency use authorization from the Food and Drug Administration for Fujifilm's Avigan. The FDA gave an EUA to two unproven antimalarial drugs over the weekend.
Abbott gets emergency use authorization for rapid Covid-19 test
The diagnostics company said it had received the EUA for use of its ID NOW system, which can detect a positive result in as low as five minutes and a negative result in 13 minutes. ID NOW is mainly used in urgent care settings.